The Prognostic Value Of The C Met Protein In The Cgga And Validation

The prognostic value of the c-Met protein in the CGGA and validation ...
The prognostic value of the c-Met protein in the CGGA and validation ...
The prognostic value of BMP4 in CGGA and validation datasets. Except ...
The prognostic value of BMP4 in CGGA and validation datasets. Except ...
The prognostic value of Rab27a in the CGGA and validation datasets ...
The prognostic value of Rab27a in the CGGA and validation datasets ...
| The prognostic value of the risk score signature both in CGGA and ...
| The prognostic value of the risk score signature both in CGGA and ...
Validation of the prognostic model in the CGGA cohort. (A and B ...
Validation of the prognostic model in the CGGA cohort. (A and B ...
Prognostic value of the signature in training and validation sets and ...
Prognostic value of the signature in training and validation sets and ...
| Prognostic validation of the 11-gene signature in the CGGA cohort ...
| Prognostic validation of the 11-gene signature in the CGGA cohort ...
| The prognostic values of CENPN in TCGA and CGGA databases. (A,C ...
| The prognostic values of CENPN in TCGA and CGGA databases. (A,C ...
Prognostic value of the risk score in TCGA and CGGA. (A,B) Distribution ...
Prognostic value of the risk score in TCGA and CGGA. (A,B) Distribution ...
| Validation of the E3RG prognostic signature in the CGGA cohort. (A ...
| Validation of the E3RG prognostic signature in the CGGA cohort. (A ...
Expression and prognostic value of YTHDF2 in glioma. A–C The mRNA ...
Expression and prognostic value of YTHDF2 in glioma. A–C The mRNA ...
Survival analysis and prognostic validity of the risk signature in CGGA ...
Survival analysis and prognostic validity of the risk signature in CGGA ...
The prognostic value of FBLIM1 levels in glioma patients using CGGA ...
The prognostic value of FBLIM1 levels in glioma patients using CGGA ...
| Prognostic value of the m1A regulators in glioma according to CGGA ...
| Prognostic value of the m1A regulators in glioma according to CGGA ...
Prognostic relevance and validation of ARPC1A in the progression of low ...
Prognostic relevance and validation of ARPC1A in the progression of low ...
MET differences in all grades and all three databases.: (A) The protein ...
MET differences in all grades and all three databases.: (A) The protein ...
| External validation of the prognostic signature in CGGA. (A ...
| External validation of the prognostic signature in CGGA. (A ...
Distribution of the CDI in CGGA validation cohort. A) Classification of ...
Distribution of the CDI in CGGA validation cohort. A) Classification of ...
Validation of the prognostic model in CGGA. (A) Heatmap of the seven ...
Validation of the prognostic model in CGGA. (A) Heatmap of the seven ...
Construction and validation of the immune prognostic signature. (A,B ...
Construction and validation of the immune prognostic signature. (A,B ...
Internal validation of the prognostic model in TCGA cohort based on ...
Internal validation of the prognostic model in TCGA cohort based on ...
| Validation of the risk signature in the CGGA testing set. (A) Patient ...
| Validation of the risk signature in the CGGA testing set. (A) Patient ...
| External validation of the seven-FRG signature model in the CGGA ...
| External validation of the seven-FRG signature model in the CGGA ...
The prognostic value of the risk signature in The Cancer Genome Atlas ...
The prognostic value of the risk signature in The Cancer Genome Atlas ...
The creation and validation of the clinical prognostic model. (A) CSRS ...
The creation and validation of the clinical prognostic model. (A) CSRS ...
CKAP2L has diagnostic value for glioma in the CGGA and TCGA databases ...
CKAP2L has diagnostic value for glioma in the CGGA and TCGA databases ...
The evaluation of six genes combined value in glioma diagnosis and ...
The evaluation of six genes combined value in glioma diagnosis and ...
The construction and validation of the prognostic signature. (A‐B ...
The construction and validation of the prognostic signature. (A‐B ...
Evaluating the efficiencies of the risk signature in the CGGA and ...
Evaluating the efficiencies of the risk signature in the CGGA and ...
The prognostic value of the TIIClnc signature. A. A total of 101 ...
The prognostic value of the TIIClnc signature. A. A total of 101 ...
Validation of the m⁶A-related prognostic signature. (a, b) The ...
Validation of the m⁶A-related prognostic signature. (a, b) The ...
Validation of prognostic value of risk scores in CGGA‐693 and CGGA‐325 ...
Validation of prognostic value of risk scores in CGGA‐693 and CGGA‐325 ...
Validation of the m⁶A-related prognostic signature. (a, b) The ...
Validation of the m⁶A-related prognostic signature. (a, b) The ...
| Validation of the prognostic performance of the risk stratification ...
| Validation of the prognostic performance of the risk stratification ...
CGGA-based Kaplan-Meier curves illustrating the prognostic value of ...
CGGA-based Kaplan-Meier curves illustrating the prognostic value of ...
The relationship between CKAP2L and the prognosis of glioma patients in ...
The relationship between CKAP2L and the prognosis of glioma patients in ...

Loading image details...

Source
Dimensions